Journal · Updated 2026-08-11
bmiMD Review 2026: The Semaglutide Price Leader's Full Ladder, Audited
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
Short answer — August 2026
bmiMD publishes the cleanest price ladder in the compounded market, and it computes to two crowns on our rankings. Semaglutide: one twenty-nine monthly, one nineteen on three months, one-oh-nine on six, ninety-nine on twelve — the cheapest month-to-month figure we track and co-holder of the ninety-nine-dollar committed floor. Tirzepatide: one seventy-nine monthly, one fifty-nine, one forty-nine, one thirty-nine on twelve — tying NexLife's promotional twelve-month rate and co-leading the monthly-billed annual tier. Same price at every dose, no membership, price varies by term only. Status: reported, from July 2026 first-party captures, our checkout capture pending. The fine print that matters: the headline figures are the twelve-month tier, and the program advertises a named 503A pharmacy — a claim worth cashing at intake by getting the actual name.
The ladder, and what "every dose" buys
The structural feature is dose-flatness: whether you're at a starter dose or full maintenance, the price is your term's price — which neutralizes the dose-anchoring teaser mechanism entirely and makes bmiMD's advertised numbers survive titration intact, a property shared by only a handful of programs (Henry, HealthRX, and the flat-rate cluster). The term ladder is the honest kind of low price: the ninety-nine and one thirty-nine figures require the twelve-month tier, billed monthly rather than upfront — a materially safer commitment shape than Trimi and LumiMeds' lump-sum annual billing, since your exposure is a month at a time even inside the term. Month-to-month exists at every dose too, at the one twenty-nine and one seventy-nine rates, which is precisely what makes the rows rankable in both our no-commitment and annual categories.
The checks before the charge
Two. First, cash the pharmacy claim: "a named 503A pharmacy" is only worth the name — get it at intake, then run the standard fifteen minutes (state license lookups including your state's non-resident register, FDA compounding records, certificate of analysis for your lot). Second, pin the term mechanics in writing: what happens if you exit a twelve-month tier early — rate re-billing at the monthly difference, or a clean walk — and whether the tier price is locked for the term. Our records carry no adverse flags on either question; they carry no confirmations either, which is what "reported, capture pending" means, and why the two questions are yours to ask before the first payment rather than after.
Verdict, against the field
On semaglutide, bmiMD is the computed leader at both bases — one twenty-nine monthly against HealthRX's one thirty-three (which has no true monthly option), NexLife's one thirty-nine promotional, and Henry's one seventy-nine; and ninety-nine committed alongside HealthRX and Trimi, with the safest billing shape of the three. On tirzepatide it's the strong second: one seventy-nine monthly ties Henry behind NexLife's promotional one sixty-nine, and one thirty-nine on twelve ties NexLife's promo while beating everything else billed monthly. The buyer it fits best: anyone semaglutide-first on price, and any tirzepatide buyer who wants the annual-tier floor without wiring fifteen hundred dollars to a prepaid plan. The buyer it fits worst: anyone who won't commit twelve months and won't pay the monthly premium — for whom the whole market's answer is the no-commitment ranking.
Questions people ask
How much is bmiMD per month?
Semaglutide: $129 monthly, $119 (3-month), $109 (6-month), $99 (12-month). Tirzepatide: $179 monthly, $159, $149, $139 (12-month). Same price at every dose, no membership; the price varies by plan length only. Twelve-month tiers bill monthly rather than upfront. Reported status from July 2026 captures.
Is bmiMD the cheapest semaglutide provider?
On our computed rankings, yes at both bases: $129 is the cheapest month-to-month all-in figure we track, and $99 co-holds the twelve-month floor with HealthRX and Trimi — with bmiMD's version billed monthly, the safest shape of the three (Trimi bills the full $1,188 upfront; HealthRX has no monthly option, shortest term $133 on three months).
What's the catch with bmiMD's $99 and $139 prices?
They're the twelve-month commitment tier — real rates, honestly laddered, but term-anchored: month-to-month costs $129/$179. Two things to pin at intake: the actual name of its advertised 503A pharmacy (then verify it), and the early-exit mechanics of the twelve-month tier, in writing.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.